Pfizer Acquire ReViral for $ 525 Millon and its Respiratory Syncytial Virus Therapeutic Candidates Sisunatovir
Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…
Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…
Synopsis : GlaxoSmithKline plc and Sierra Oncology, Inc have announced that GSK will acquire Sierra Oncology, a California-based late-stage biopharmaceutical company focused…
Summary : Sandoz acquired the capabilities and assets of drug delivery device company, Coalesce, to further its existing portfolio of respiratory medicines…
Summary MGK, a subsidiary of Sumitomo Chemical Company, purchased the DeBug brand of neem products from Agro Logistic Systems. The DeBug products…
Summary Pharma major Aurobindo Pharmaceuticals on Monday said it has acquired the business and certain assets of Veritaz Healthcare Limited (VHL) for…
Summary : Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced…
Summary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
Summary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr),…
Summary : BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year from Renuka Ramnath-led private equity (PE) fund…
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…